Average Co-Inventor Count = 5.89
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (24 from 3,681 patents)
2. Schering Corporation (18 from 1,829 patents)
42 patents:
1. 10196387 - Carbazole compounds useful as bromodomain inhibitors
2. 10053454 - Carbazole compounds useful as bromodomain inhibitors
3. 9751879 - Tricyclic compounds as anticancer agents
4. 9725449 - Tricyclic compounds as anticancer agents
5. 9556178 - Imidazotriazinecarbonitriles useful as kinase inhibitors
6. 9273057 - Imidazotriazinecarbonitriles useful as kinase inhibitors
7. 8940736 - Imidazotriazinecarbonitriles useful as kinase inhibitors
8. 8389527 - Substituted imidazopyridazines useful as kinase inhibitors
9. 7968577 - Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
10. 7923556 - Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
11. 7741289 - Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
12. 7723336 - Fused heterocyclic compounds useful as kinase modulators
13. 7544808 - Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
14. 7541362 - Heterocyclic dihydropyrimidine compounds
15. 7439246 - Fused heterocyclic kinase inhibitors